Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 12 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-33.53 Insider Own4.44% Shs Outstand1.96M Perf Week-1.57%
Market Cap7.37M Forward P/E- EPS next Y-3.63 Insider Trans0.00% Shs Float1.87M Perf Month-3.84%
Income-7.71M PEG- EPS next Q-2.40 Inst Own17.62% Short Float2.62% Perf Quarter-74.47%
Sales0.00M P/S- EPS this Y76.08% Inst Trans- Short Ratio0.14 Perf Half Y-83.16%
Book/sh27.15 P/B0.14 EPS next Y51.11% ROA-102.20% Short Interest0.05M Perf Year-87.95%
Cash/sh4.99 P/C0.75 EPS next 5Y- ROE-160.79% 52W Range3.48 - 61.20 Perf YTD-82.88%
Dividend Est.- P/FCF- EPS past 5Y70.74% ROI-95.22% 52W High-93.86% Beta2.27
Dividend TTM- Quick Ratio3.26 Sales past 5Y0.00% Gross Margin- 52W Low8.05% ATR (14)0.42
Dividend Ex-Date- Current Ratio3.26 EPS Y/Y TTM94.60% Oper. Margin0.00% RSI (14)39.96 Volatility6.97% 6.64%
Employees5 Debt/Eq0.06 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price32.50
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q87.85% Payout- Rel Volume0.06 Prev Close3.87
Sales Surprise- EPS Surprise-11.51% Sales Q/Q- EarningsMar 28 BMO Avg Volume355.53K Price3.76
SMA20-2.92% SMA50-24.60% SMA200-79.72% Trades Volume21,905 Change-2.84%
Date Action Analyst Rating Change Price Target Change
May-18-17Upgrade Ladenburg Thalmann Neutral → Buy
Dec-16-14Initiated MLV & Co Buy $7
Nov-18-14Initiated WallachBeth Buy $12
Apr-09-24 08:30AM
Mar-28-24 09:54PM
Mar-12-24 08:30AM
Feb-29-24 09:00AM
08:30AM Loading…
Feb-20-24 08:30AM
Feb-08-24 08:53AM
Feb-07-24 08:01PM
Feb-06-24 08:30AM
Dec-29-23 08:30AM
Nov-17-23 08:30AM
Nov-14-23 05:05AM
Nov-13-23 03:22PM
08:20AM Loading…
Aug-28-23 08:20AM
Aug-25-23 07:20AM
Jul-19-23 08:30AM
Jun-23-23 06:24AM
May-31-23 08:54AM
May-22-23 06:44AM
Apr-21-23 03:59PM
Apr-12-23 02:50PM
Apr-05-23 05:49AM
Mar-22-23 08:45AM
Feb-17-23 07:05AM
Feb-15-23 08:05AM
Feb-07-23 12:10PM
Feb-03-23 08:19AM
10:43AM Loading…
Feb-02-23 10:43AM
Feb-01-23 04:31PM
Jan-04-23 08:00AM
Nov-03-22 07:16AM
Oct-10-22 08:30AM
Sep-15-22 09:29AM
Aug-28-22 09:23AM
Aug-23-22 05:58AM
Jul-01-22 07:52AM
May-25-22 08:30AM
May-23-22 08:30AM
May-19-22 08:18AM
May-18-22 08:30AM
Apr-01-22 09:25AM
Mar-31-22 08:30AM
Mar-30-22 05:00PM
Jan-31-22 04:10PM
Jan-12-22 08:30AM
Jan-05-22 11:48AM
Jan-04-22 08:30AM
Nov-18-21 11:54AM
Nov-16-21 08:30AM
Oct-06-21 08:30AM
Sep-28-21 08:30AM
Sep-20-21 10:43AM
Sep-09-21 08:00AM
Aug-17-21 08:00AM
Aug-12-21 08:00AM
Aug-05-21 08:00AM
Jul-16-21 12:40PM
Jul-07-21 08:00AM
Jun-14-21 04:25PM
Jun-10-21 08:30AM
Jun-07-21 04:52PM
May-17-21 05:15PM
Apr-14-21 07:45AM
Apr-09-21 11:38AM
Apr-07-21 04:45PM
Mar-31-21 04:45PM
Mar-04-21 08:30AM
Mar-02-21 08:15AM
Jan-20-21 10:30AM
Jan-19-21 07:45AM
Dec-29-20 04:29PM
Dec-03-20 07:47AM
Nov-29-20 07:28PM
Nov-16-20 04:45PM
Nov-10-20 08:30AM
Nov-06-20 08:30AM
Oct-15-20 08:30AM
Oct-02-20 08:30AM
Sep-01-20 10:44AM
Aug-31-20 08:30AM
Aug-28-20 10:54AM
Aug-17-20 08:00AM
Jul-20-20 08:45AM
Jul-06-20 07:50PM
Jun-03-20 09:41AM
Jun-02-20 07:30AM
Jun-01-20 05:30AM
May-29-20 01:07PM
Apr-13-20 05:55AM
Apr-09-20 08:30AM
Mar-19-20 10:16AM
Mar-12-20 08:30AM
Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.